Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-054823·Bain Capital Life Sciences Opportunities IV, L.P.
Schedule 13G ownership disclosure
Olema Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 68062P106
Event date: 2025-12-31
- Filing-level shares
- 8,508,641
- Percent of class
- 9.99%
- Bain Capital Life Sciences Opportunities IV, L.P.
Shares: 8,508,641 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-054823
- Form type
- SCHEDULE 13G/A
- Filer
- Bain Capital Life Sciences Opportunities IV, L.P.
- CIK
- CIK 2015553
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership